Skip to navigation Skip to content
  • The Cancer Letter on Facebook
  • The Cancer Letter on Twitter
  • The Cancer Letter on LinkedIn

The Cancer Letter

The leading source for information on the issues that shape oncology since 1973

Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
  • SUBSCRIBE
  • Login
  • SUBSCRIBE
  • Login
The Cancer Letter
Home
  • About
    • Our Readers
    • Our History
    • Our Contributors
    • Contact Us
    • Store
  • Current Issue
    • Past Issues
  • Podcast
    • The Directors
  • Events
  • Job Board
In Brief

With $60M in gifts, NYU Langone to create Mignone Women’s Health Collaborative and treat women at every life stage

NYU Langone announced on May 21 the creation of the Mignone Women’s Health Collaborative, building upon the system’s health care services for women and deepening coordination between specialists who work together to treat women at every stage of life.
May 23, 2025
Vol.51 No.20
Alec Kimmelman announced as next CEO and Dean of NYU Langone Health
In Brief

Alec Kimmelman announced as next CEO and Dean of NYU Langone Health

Alec C. Kimmelman was named CEO and dean of NYU Grossman School of Medicine.
April 04, 2025
Vol.51 No.13
Clinical Roundup

Psychedelic drug therapy may address mental health concerns in people with cancer and addiction

One or two doses of psilocybin, a compound found in psychedelic mushrooms, may improve the mental health of cancer patients when accompanied by psychotherapy, a new report suggests. A second new study found that treatment with psilocybin resulted in lasting, positive personality changes in patients with alcohol use disorder.
January 10, 2025
Vol.51 No.01
Clinical Roundup

Hair growth drug safe at low doses for breast cancer patients

A study in women with breast cancer suggests that low oral doses of minoxidil, taken during or after cancer treatment, appear to regrow hair in most patients and without causing any serious heart-related side effects that require additional therapies or hospitalization.
December 13, 2024
Vol.50 No.46
Clinical Roundup

NYU study details how cancer cells evade chemotherapy

Laboratory experiments with cancer cells reveal two ways in which tumors evade chemotherapy drugs designed to starve and kill them, a new study in Nature Metabolism shows.
December 06, 2024
Vol.50 No.45
Clinical Roundup

Remote telemedicine tool found highly accurate in diagnosing melanoma

Collecting images of suspicious-looking skin growths and sending them off-site for specialists to analyze is as accurate in identifying skin cancers as having a dermatologist examine them in person, a new study shows.
November 22, 2024
Vol.50 No.44
Clinical Roundup

DNA methylation contributes to 9/11-related breast cancers

A study led by researchers at NYU Langone Health and its Perlmutter Cancer Center has highlighted the role of DNA methylation in the increased risk of several cancers, including breast cancer, among rescuers and survivors of the attack on the World Trade Center on Sept. 11, 2001, in New York City.
September 13, 2024
Vol.50 No.34

Trending Stories

  • The faces of RIF: Staff members of NCI’s dissolved communications team gather for a farewell group photo
  • As Trump decimates NIH funding, a daring proposal to issue $750 billion in bonds for medical cures garners attention
  • Lou Weisbach tells us about his plan to raise $750 billion for the American Center for Cures
  • NIH Director Jay Bhattacharya launches a podcast
  • In the Headlines: Missing record of NCAB meetings restored to NIH website
  • Senators slam Bhattacharya for deflecting responsibility for NIH cuts, upheaval
    Susan Collins: Trump’s 40% cut is “so disturbing”

ABOUT
ABOUT
About The Cancer Letter
Accessibility Statement
Our Contributors
Editorial policies
Store
SUBSCRIPTIONS
SUBSCRIPTIONS
Our readers
Pricing
News alerts
About IP login
Job board
CONTACT
CONTACT
Contact us
Submission guidelines
Advertise
Careers
SEE ALSO
Cancer History Project
The Cancer Letter
Copyright © 2025 The Cancer Letter Inc. All rights reserved.
Privacy Policy
Terms & Conditions
FOLLOW US
Instagram
Twitter
LinkedIn
Facebook
Vimeo
Scroll to top
Request Cancellation
Subscription Change

This change will be effective immediately and your card will be charged a prorated amount based on your existing subscription level.

OK Cancel

Renew today!

Your subscription has lapsed. Subscribe today to access this content.
SUBSCRIBE NOW

Subscriber content

Log in or subscribe to access The Cancer Letter.
LOGINSUBSCRIBE NOW
SEARCH DATE
SEARCH TEXT
      Cancel
      OK
      Cancel
      OK
      Delete Account
      Are you sure you want to delete your account? This will erase all of your account data from the site. To delete your account enter your password below
      No

      Never miss an issue!

      Get alerts for our award-winning coverage in your inbox.

      Login

       
      Forgot Password?

      Site license subscribers:
      Log in with your IP | Register a sponsored account